As of June 20, 2025, FluoroPharma Medical Inc (FPMI) reports a Gross Margin of 88.24%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of FluoroPharma Medical Inc's Gross Margin
Over recent years, FluoroPharma Medical Inc's Gross Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2016-12-31 | 88.24% |
| 2015-12-31 | 88.24% |
| 2014-12-31 | 90.91% |
This fluctuation highlights how FluoroPharma Medical Inc manages its operational efficiency and pricing power over time.
Comparing FluoroPharma Medical Inc's Gross Margin to Peers
To better understand FluoroPharma Medical Inc's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| FluoroPharma Medical Inc (FPMI) | 88.24% |
| W World Corp (WWHC) | 7775.20% |
| Rocket Pharmaceuticals Inc (RCKT) | 7775.20% |
| Atreca Inc (BCEL) | 7775.20% |
| Oncovista Innovative Therapies Inc (OVIT) | 7775.20% |
| Omnimmune Holdings Inc (OMMH) | 7775.20% |
Compared to its competitors, FluoroPharma Medical Inc's Gross Margin is about average compared to peers, indicating industry-standard operational efficiency.